Boston Scientific (NYSE:BSX – Get Rating) had its target price hoisted by Barclays from $53.00 to $56.00 in a research report report published on Thursday morning, The Fly reports. A number of other research analysts have also commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Boston Scientific from […]
Boston Scientific (NYSE:BSX – Get Rating) updated its second quarter 2023 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.48-$0.50 for the period, compared to the consensus estimate of $0.48. The company issued revenue guidance of $3.46 billion-$3.52 billion, compared to the consensus revenue estimate of $3.44 billion. Boston Scientific […]
Boston Scientific (NYSE:BSX – Get Rating) issued an update on its FY 2023 earnings guidance on Thursday morning. The company provided EPS guidance of $1.90-$1.96 for the period, compared to the consensus EPS estimate of $1.91. The company issued revenue guidance of $13.76 billion-$14.01 billion, compared to the consensus revenue estimate of $13.55 billion. Boston […]
Summit Financial LLC grew its position in shares of Boston Scientific Co. (NYSE:BSX – Get Rating) by 10.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 15,759 shares of the medical equipment provider’s stock after buying an additional 1,451 shares […]
Boston Scientific Co. (NYSE:BSX – Get Rating) – Analysts at Jefferies Financial Group boosted their Q2 2023 earnings per share estimates for shares of Boston Scientific in a research report issued to clients and investors on Wednesday, April 26th. Jefferies Financial Group analyst M. Taylor now forecasts that the medical equipment provider will post earnings […]